STOCK TITAN

Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Abiomed, Inc. (NASDAQ: ABMD), a frontrunner in heart, lung, and kidney support technologies, has announced that Michael R. Minogue, its Chairman, President, and CEO, will present at the William Blair 42nd Annual Growth Stock Conference. The presentation is scheduled for Monday, June 6, 2022, at 2:00 PM CT. Based in Danvers, Massachusetts, Abiomed specializes in medical devices that enhance blood flow and oxygenation, assisting patients in respiratory failure.

Positive
  • None.
Negative
  • None.

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT.

ABOUT ABIOMED

Based in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Investor:

Todd Trapp

Vice President and Chief Financial Officer

+1 (978) 646-1680

ttrapp@abiomed.com



Media:

Jenny Leary

Associate Director, U.S. Communications

+1 (978) 882-8491

jleary@abiomed.com

Source: Abiomed, Inc.

FAQ

When is Abiomed's presentation at the William Blair Growth Stock Conference?

Abiomed's presentation will take place on June 6, 2022, at 2:00 PM CT.

Who is presenting for Abiomed at the conference?

The presentation will be given by Michael R. Minogue, Chairman, President, and CEO of Abiomed.

What does Abiomed, Inc. specialize in?

Abiomed specializes in providing medical devices for circulatory support and oxygenation.

Where is Abiomed, Inc. headquartered?

Abiomed is headquartered in Danvers, Massachusetts.

What stock symbol is associated with Abiomed, Inc.?

Abiomed, Inc. is listed under the stock symbol ABMD.

Abiomed, Inc.

NASDAQ:ABMD

ABMD Rankings

ABMD Latest News

ABMD Stock Data

17.18B
44.19M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Danvers